Fundraising Fox
Xtant Medical Holdings
NYSE: XTNTBelgrade, US · Delaware corporation · 1 known investors
Find your way into Xtant Medical Holdings
Sign up to see every warm intro you have to Xtant Medical Holdings
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Xtant Medical Holdings team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Xtant Medical is a tissue bank and developer of orthobiologics and spinal fixation systems, with vertically integrated operations from donor tissue recovery to distribution. It provides surgeons with biologic grafts and cervical, thoracolumbar, and interbody spinal implant systems for complex, deformity, and degenerative procedures.
Founders & leadership
KD
Kevin D. BrandtExecutiveKevin D. Brandt is an executive officer at Xtant Medical Holdings with experience in the medical device industry, particularly in spine and FDA-regulated products. He holds an MBA in Corporate Finance and Investments from Adelphi University.
JP
Jeffrey PetersNamed on SEC filing
ME
Michael EggenbergNamed on SEC filing
GJ
Greg JensenNamed on SEC filing
Board
MR
Matthew RizzoBoard director
RM
Robert McNamaraBoard director
SG
Stavros G. VizirgianakisBoard director
LD
Lori D. Mitchell-KellerBoard director
JK
John K. BakewellBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$109.6M disclosed across 5 rounds · 2020–2024
▶$5MraisedAug 2024 · 5 investors · Other Health CareRule 506(b)
▶$5MraisedAug 2024 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Robert E. McNamaraDirector
- Kevin D BrandtExecutive Officer
- Stavros G. VizirgianakisDirector
- Scott C. NeilsExecutive Officer
- Lori D. Mitchell-KellerDirector
- John K. BakewellDirector
- Mark A. SchallenbergerExecutive Officer
- Sean E. BrowneExecutive Officer, Director
- Jonn R. BeesonDirector
- Offering amount
- $5M
- Amount sold
- $5M
- Sales commissions
- $350K
- Placement agents
- Craig-Hallum Capital Group LLC
- First sale
- Aug 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15MraisedJul 2023 · 22 investors · Other Health CareRule 506(b)
▶$15MraisedJul 2023 · 22 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mark A. SchallenbergerExecutive Officer
- Sean E. BrowneExecutive Officer, Director
- Lori D. Mitchell-KellerDirector
- Jonn R. BeesonDirector
- John K. BakewellDirector
- Stavros G. VizirgianakisDirector
- Kevin D. BrandtExecutive Officer
- Scott C. NeilsExecutive Officer
- Robert E. McNamaraDirector
- Offering amount
- $15M
- Amount sold
- $15M
- Sales commissions
- $812K
- Placement agents
- Craig-Hallum Capital Group LLC
- First sale
- Jul 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.7MraisedAug 2022 · 11 investors · Other Health CareRule 506(b)
▶$6.7MraisedAug 2022 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michael EggenbergDirector
- Jeffrey PetersDirector
- Stavros G. VizirgianakisDirector
- Sean E. BrowneExecutive Officer, Director
- Kevin D. BrandtExecutive Officer
- John BakewellDirector
- Scott C. NeilsExecutive Officer
- Matthew RizzoDirector
- Robert McNamaraDirector
- Offering amount
- $9.7M
- Amount sold
- $6.7M
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$20MraisedFeb 2021 · 1 investors · Other Health CareRule 506(b)
▶$20MraisedFeb 2021 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Sean E. BrowneExecutive Officer, Director
- Robert McNamaraDirector
- Matthew RizzoDirector
- Michael EggenbergDirector
- John BakewellDirector
- Jeffrey PetersDirector
- Kevin D. BrandtExecutive Officer
- Greg JensenExecutive Officer
- Offering amount
- $36.3M
- Amount sold
- $20M
- Sales commissions
- $1.4M
- Placement agents
- A.G.P./Alliance Global Partners
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$62.9MraisedOct 2020 · 2 investors · Other Health CareRule 506(b)
▶$62.9MraisedOct 2020 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey PetersDirector
- Matthew RizzoDirector
- Sean E. BrowneExecutive Officer, Director
- John BakewellDirector
- Robert McNamaraDirector
- Michael EggenbergDirector
- Kevin D. BrandtExecutive Officer
- Greg JensenExecutive Officer
- Offering amount
- $62.9M
- Amount sold
- $62.9M
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Xtant Medical Holdings do?
- Xtant Medical is a tissue bank and developer of orthobiologics and spinal fixation systems, with vertically integrated operations from donor tissue recovery to distribution. It provides surgeons with biologic grafts and cervical, thoracolumbar, and interbody spinal implant systems for complex, deformity, and degenerative procedures.
- Who are Xtant Medical Holdings's investors?
- Xtant Medical Holdings's investors include Western Technology Investment.
- How much funding has Xtant Medical Holdings raised?
- Xtant Medical Holdings has disclosed $109.6M raised across 5 rounds.
- Where is Xtant Medical Holdings headquartered?
- Xtant Medical Holdings is headquartered in Belgrade, US.